Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M616Revenue $M25.1Net Margin (%)-774.1Altman Z-Score-9.7
Enterprise Value $M877EPS $-1.4Operating Margin %-615.8Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-774.7Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsY
Price/Sales20.75-y EBITDA Growth Rate %--Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-59.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M196ROIC % (ttm)-156.6Gross Margin Increase y-yN

Gurus Latest Trades with EXEL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXELFirst Eagle Investment 2014-06-30 Sold Out $3.22 - $3.8
($3.45)
$ 3.14-9%Sold Out0
EXELFirst Eagle Investment 2014-03-31 Reduce-0.01%$3.38 - $8.24
($6.84)
$ 3.14-54%Reduce 65.91%400,000
EXELFirst Eagle Investment 2012-09-30 Add0.02%$4.28 - $6.45
($5.29)
$ 3.14-41%Add 422.58%1,175,800
EXELFirst Eagle Investment 2012-03-31 Add$4.49 - $6.47
($5.14)
$ 3.14-39%Add 125.00%225,000
EXELFirst Eagle Investment 2011-12-31 Buy $3.95 - $7.81
($5.01)
$ 3.14-37%New holding100,000
EXELCarl Icahn 2011-09-30 Sold Out -0.43%$5.5 - $9.22
($7.34)
$ 3.14-57%Sold Out0
EXELFirst Eagle Investment 2011-03-31 Sold Out $7.22 - $12.45
($9.89)
$ 3.14-68%Sold Out0
EXELFirst Eagle Investment 2010-12-31 Buy 0.01%$3.98 - $9.08
($5.66)
$ 3.14-45%New holding280,000
EXELFirst Eagle Investment 2009-12-31 Sold Out -0.02%$5.33 - $8
($6.86)
$ 3.14-54%Sold Out0
EXELFirst Eagle Investment 2009-09-30 Buy 0.02%$4.4 - $6.99
($5.65)
$ 3.14-44%New holding274,700
EXELFirst Eagle Investment 2009-06-30 Sold Out -0.01%$4.16 - $5.55
($4.88)
$ 3.14-36%Sold Out0
EXELFirst Eagle Investment 2009-03-31 Reduce$4.32 - $5.85
($4.8)
$ 3.14-35%Reduce 25.67%144,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXEL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


EXEL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MARCHESI VINCENT TDirector 2014-09-17Buy20,000$1.7183.63 view
WILLSEY LANCEDirector 2013-08-29Buy10,000$5.15-39.03 view
MARCHESI VINCENT TDirector 2012-12-20Buy4,000$4.68-32.91 view
MARCHESI VINCENT TDirector 2012-12-19Buy6,000$4.72-33.47 view
Schwab GiselaEVP and Chief Medical Officer 2012-12-10Buy25,000$4.39-28.47 view
MARCHESI VINCENT TDirector 2012-06-14Sell7,000$5.13-38.79 view
RIVERA LUPE MEVP, Operations 2010-12-17Sell29,427$8.5-63.06 view
RIVERA LUPE MEVP, Operations 2010-12-15Sell75,000$7.5-58.13 view
Schwab GiselaEVP & Chief Medical Officer 2010-12-09Sell4,112$6.5-51.69 view
WILLSEY LANCEDirector 2010-09-07Buy36,200$3.6-12.78 view

Press Releases about EXEL :

    Quarterly/Annual Reports about EXEL:

    News about EXEL:

    Articles On GuruFocus.com
    5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and Aeropostale I Dec 28 2014 
    5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc. Sep 28 2014 
    Weekly 3-Year Low Highlights: UAN, CLD, EXEL, QNST Sep 06 2014 
    Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian Trust, Millennial Media Inc., Exelix May 05 2014 
    5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
    Exelixis Inc. Reports Operating Results (10-K) Feb 22 2011 
    Exelixis Inc. (EXEL) CFO Frank Karbe buys 16,500 Shares Aug 25 2010 
    Exelixis Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Exelixis Inc. Reports Operating Results (10-Q) May 11 2010 
    Exelixis Announces Second Quarter 2009 Financial Results Jul 30 2009 

    More From Other Websites
    6 stocks to watch May 13 2015
    Exelixis (EXEL) Worth Watching: Stock Moves 10.3% Higher - Tale of the Tape May 11 2015
    Exelixis (EXEL) Stock Spikes on First Quarter Earnings Report May 08 2015
    How 42 Words Completely Changed Exelixis' Report May 04 2015
    Exelixis to Present at the Bank of America Merrill Lynch 2015 Health Care Conference on May 12 May 04 2015
    Exelixis to Present at the Bank of America Merrill Lynch 2015 Health Care Conference on May 12 May 04 2015
    Exelixis reports 1Q loss Apr 30 2015
    Exelixis reports 1Q loss Apr 30 2015
    Exelixis Inc Earnings Call scheduled for 5:00 pm ET today Apr 30 2015
    Exelixis Announces First Quarter 2015 Financial Results and Provides Corporate Update Apr 30 2015
    4:42 pm Exelixis beats by $0.06, beats on revs Apr 30 2015
    Cabozantinib and Cobimetinib to Be Featured in Fourteen Presentations at 2015 ASCO Annual Meeting Apr 30 2015
    Exelixis Announces First Quarter 2015 Financial Results and Provides Corporate Update Apr 30 2015
    EXELIXIS, INC. Files SEC form 8-K/A, Costs Associated with Exit or Disposal Activities Apr 30 2015
    Q1 2015 Exelixis Inc Earnings Release - After Market Close Apr 30 2015
    Will Endocyte (ECYT) Disappoint This Earnings Season? - Analyst Blog Apr 29 2015
    Is Exelixis (EXEL) Likely to Report Narrower Loss in Q1? - Analyst Blog Apr 29 2015
    Will Vertex (VRTX) Surprise with a Lower Loss in Q1? - Analyst Blog Apr 28 2015
    Will AmerisourceBergen (ABC) Beat on Earnings Yet Again? - Analyst Blog Apr 28 2015
    Will Epizyme (EPZM) Beat Estimates This Earnings Season? - Analyst Blog Apr 27 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK